Streetbeat News

Stock Prices

AMRC

Ameresco (NYSE:AMRC) has received various analyst ratings over the last quarter, with 2 bullish, 4 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 8 analysts is $46.38, with a high of $59.00 and a low of $37.00. This target has decreased by 20.27% from the previous average of $58.17. Analyst ratings are opinions based on financial analysis and are meant to provide guidance to investors.

Portfolio Pulse from Benzinga Insights

December 15, 2023 | 2:00 pm

CXDO

DCTH

ELYS

TWOU

Insiders at Delcath Systems, 2U, Crexendo, and Elys Game Technology have recently purchased shares of their respective companies. Delcath Systems' Chief Medical Officer bought 40,000 shares at $3.00 each, while 2U's Chief Product Officer acquired 51,565 shares at $0.99 each. Crexendo's Chief Revenue Officer purchased 2,000 shares at $3.03 each, and Elys Game Technology's 10% owner bought 807,530 shares at $0.16 each. These transactions may signal insider confidence despite Delcath Systems' poor quarterly results and 2U's mixed financial results with reduced revenue guidance.

Portfolio Pulse from Avi Kapoor

December 15, 2023 | 2:00 pm

MRK

NVS

The FDA has approved Merck & Co Inc's (NYSE:MRK) drug Welireg (belzutifan) for advanced renal cell carcinoma (RCC) in patients previously treated with PD-1/PD-L1 inhibitors and VEGF-TKI. This marks the first new treatment class approved for advanced RCC since 2015. The approval is based on the LITESPARK-005 trial results, where Welireg showed superior progression-free survival (PFS) and objective response rate (ORR) compared to Novartis AG's (NYSE:NVS) Afinitor (everolimus). MRK shares rose 0.58% in premarket trading.

Portfolio Pulse from Vandana Singh

December 15, 2023 | 1:59 pm

BATL

Battalion Oil Corporation has agreed to a merger with Fury Resources, with Fury set to acquire all outstanding shares of Battalion at $9.80 per share. The deal is valued at approximately $450 million and is expected to close in the first quarter of 2024, pending customary closing conditions and approval from Battalion's stockholders.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:58 pm

BRSH

Bruush Oral Care's stock is trading higher following the announcement of a merger agreement with Arrive Technology.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:57 pm

GETR

Getaround's stock price has risen following the announcement of improved financial results for Q3, indicating a year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:54 pm

LQR

LQR House has regained compliance with the Nasdaq's minimum bid price requirement by maintaining its stock price above the $1 minimum bid price for 10 consecutive days.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:54 pm

PRTH

Priority Tech shares have risen following an upgrade from B. Riley Securities, which changed its rating from Neutral to Buy and increased the price target from $5 to $10.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:53 pm

PGR

Progressive Corporation (NYSE:PGR) reported its November 2023 results with a net income of $680.6 million and earnings per share (EPS) of $1.15. Net premiums written were $4,725.1 million, and net premiums earned were $5,079.0 million. The company saw a combined ratio of 91.1 for the current year, an improvement from the prior year's 92.2. Progressive also reported a total pretax net realized gains on securities of $246.5 million. Policies in force increased across all categories, with personal auto up by 9%, special lines by 7%, and property business by 8%. The company has modified its earnings release content due to a change in its monthly accounting closing calendar to align with the Gregorian calendar, which may affect year-over-year comparisons from October 2023 through September 2024.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:50 pm

BA

UBS analyst Gavin Parsons has reaffirmed a Buy rating on Boeing (NYSE:BA) and increased the price target from $275 to $315, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 1:50 pm